UK Antitrust Arm Mulling Bipolar Drug Co.'s Commitments
The U.K.'s antitrust regulator is mulling over concessions pharmaceutical company Essential Pharma has said it will make after announcing it planned to withdraw a bipolar medication from the U.K. market and...To view the full article, register now.
Already a subscriber? Click here to view full article